Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody.
Kett DH, Quartin AA, Sprung CL, Fisher CJ Jr, Peña MA, Heard SO, Zimmerman JL, Albertson TE, Panacek EA, Eidelman LA, et al. Kett DH, et al. Among authors: panacek ea. Crit Care Med. 1994 Aug;22(8):1227-34. doi: 10.1097/00003246-199408000-00005. Crit Care Med. 1994. PMID: 8045141 Clinical Trial.
HA-1A in septic patients with ARDS: results from the pivotal trial.
Bigatello LM, Greene RE, Sprung CL, Panacek EA, Straube RC, Zimmerman JL, Maunder RJ, Lanken PN, Pile-Spellmann E, Stanek KS, et al. Bigatello LM, et al. Among authors: panacek ea. Intensive Care Med. 1994 May;20(5):328-34. doi: 10.1007/BF01720904. Intensive Care Med. 1994. PMID: 7930026 Clinical Trial.
Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
Albertson TE, Panacek EA, MacArthur RD, Johnson SB, Benjamin E, Matuschak GM, Zaloga G, Maki D, Silverstein J, Tobias JK, Haenftling K, Black G, Cowens JW; MAB-T88 Sepsis Study Group. Albertson TE, et al. Among authors: panacek ea. Crit Care Med. 2003 Feb;31(2):419-27. doi: 10.1097/01.CCM.0000045564.51812.3F. Crit Care Med. 2003. PMID: 12576946 Clinical Trial.
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C; Monoclonal Anti-TNF: a Randomized Controlled Sepsis Study Investigators. Panacek EA, et al. Crit Care Med. 2004 Nov;32(11):2173-82. doi: 10.1097/01.ccm.0000145229.59014.6c. Crit Care Med. 2004. PMID: 15640628 Clinical Trial.
Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation.
Molinari L, Heskia F, Peerapornratana S, Ronco C, Guzzi L, Toback S, Birch R, Beyhaghi H, Kwan T, Kampf JP, Yealy DM, Kellum JA; Sapphire and Protocolized Care for Early Septic Shock (ProCESS) Investigators. Molinari L, et al. Crit Care Med. 2021 Oct 1;49(10):1706-1716. doi: 10.1097/CCM.0000000000005061. Crit Care Med. 2021. PMID: 33927121 Free PMC article.
123 results